Evidence map›Paper›PMID 31331047›Full record

ReviewJournal of clinical medicine2019

How to Diagnose and Treat Local Allergic Rhinitis: A Challenge for Clinicians.

Ibon Eguiluz-Gracia, Natalia Pérez-Sánchez, Gádor Bogas, Paloma Campo, Carmen Rondón

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 66 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Neuronal-Immune Cell Units in Allergic Inflammation in the Nose.International journal of molecular sciences · 2022
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Management of allergic rhinitis with leukotriene receptor antagonists versus selective H1-antihistamines: a meta-analysis of current evidence.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ibon Eguiluz-GraciaAllergy Department, IBIMA-Hospital Regional Universitario de Malaga-ARADyAL, Málaga 29009, Spain. iboneguiluz@gmail.com.ORCID 0000-0002-3774-931X
Natalia Pérez-SánchezAllergy Department, IBIMA-Hospital Regional Universitario de Malaga-ARADyAL, Málaga 29009, Spain.
Gádor BogasAllergy Department, IBIMA-Hospital Regional Universitario de Malaga-ARADyAL, Málaga 29009, Spain.ORCID 0000-0003-1868-3471
Paloma CampoAllergy Department, IBIMA-Hospital Regional Universitario de Malaga-ARADyAL, Málaga 29009, Spain.
Carmen RondónAllergy Department, IBIMA-Hospital Regional Universitario de Malaga-ARADyAL, Málaga 29009, Spain.
Hospital Regional Universitario de Málaga · ES

Funding

European Regional Development Fund PI17/01410, CM17/0140, CM17/0141, RD16/0006/0001Instituto de Salud Carlos III CM17/0140Instituto de Salud Carlos III CM17/0141Instituto de Salud Carlos III PI17/01410Instituto de Salud Carlos III RD16/0006/0001
6 · The paper itself

Abstract

Chronic rhinitis is a very common disease that can be divided in various phenotypes. Historically, the condition has been classified into the allergic rhinitis (AR) and non-allergic non-infectious rhinitis (NAR) forms, based on the results of the classical biomarkers of atopy: skin prick test and serum allergen-specific IgE However, this classification does not reflect the complexity of the rhinitis syndrome, as illustrated by the existence of non-atopic rhinitis patients who display a nasal reactivity to environmental allergens. This new phenotype has been termed local allergic rhinitis (LAR) and can be only recognized if an additional test such as the nasal allergen challenge (NAC) is integrated in the diagnostic algorithm for chronic rhinitis. Recent data shows that the NAC is a very safe and reliable technique ready for the clinical practice. LAR is a differentiated rhinitis phenotype which often commences during childhood and quickly progresses towards a clinical worsening and the association of comorbidities in other mucosal organs. Recent evidence supports the existence of a bronchial counterpart of LAR (local allergic asthma), which highlights the pathophysiological links between the upper and lower airways and reinforces the united airways concept. Importantly, several controlled studies have demonstrated the ability of allergen immunotherapy to control LAR symptoms while the therapy is being administered. This review emphasizes the need to implement the NAC in the clinical practice in order to facilitate the recognition of LAR patients, allowing for an early prescription of specific therapies with disease-modifying potential.

Indexed as

allergen immunotherapylocal allergic rhinitisnasal allergen challenge

Identifiers

PMID31331047
PMCPMC6678883
OpenAlexW2963627290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.